| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037
Hepatitis B virus (HBV) transgenic mice that are immunologically tolerant to HBV-encoded Ags represent a model of chronic HBV infection suitable for the development of therapeutic immunization strategies before testing in humans. Five lineages of HBV transgenic mice were immunized with plasmid DNA that encodes hepatitis B surface Ag (HBsAg) or with cytokine-activated bone marrow-derived dendritic cells (DCs) in an attempt to break tolerance to HBsAg at the B and T cell levels. DNA immunization stimulated an Ab response but not a cytotoxic T lymphocyte response to HBsAg in two of the five transgenic lineages studied. In contrast, infusion of activated transgenic or nontransgenic DCs stimulated a splenic CTL response in all three transgenic lineages immunized in this manner at precursor frequencies comparable to those in nontransgenic mice, indicating that DC function is normal, and HBsAg-specific CTLs are present but functionally silent in these transgenic animals. Importantly, none of the animals developed hepatitis or displayed suppressed viral gene expression or replication following either DNA immunization or DC administration even in the presence of anti-hepatitis B surface (HBs) Abs and HBs-specific CTLs. These results indicate that Ag presentation by cytokine-activated DCs can break tolerance and trigger an anti-viral CTL response in HBV transgenic mice, and they suggest that this strategy is more efficient than DNA immunization in this setting. Nonetheless, more efficient immunization strategies are needed to stimulate an immune response of sufficient quality and magnitude to achieve an immunotherapeutic antiviral effect.
This article has been cited by other articles:
|
|
 |
|
  H. Ito, K. Ando, T. Ishikawa, T. Nakayama, M. Taniguchi, K. Saito, M. Imawari, H. Moriwaki, T. Yokochi, S. Kakumu, et al. Role of V{alpha}14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of V{alpha}14+ NKT cells promotes the breakage of CTL tolerance Int. Immunol., July 1, 2008; 20(7): 869 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Maier, M. Isogawa, G. J. Freeman, and F. V. Chisari PD-1:PD-L1 Interactions Contribute to the Functional Suppression of Virus-Specific CD8+ T Lymphocytes in the Liver J. Immunol., March 1, 2007; 178(5): 2714 - 2720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ebata, Y. Shimizu, Y. Nakayama, M. Minemura, J. Murakami, T. Kato, S. Yasumura, T. Takahara, T. Sugiyama, and S. Saito Immature NK Cells Suppress Dendritic Cell Functions during the Development of Leukemia in a Mouse Model J. Immunol., April 1, 2006; 176(7): 4113 - 4124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Loirat, M. Mancini-Bourgine, J.-P. Abastado, and M.-L. Michel HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection Int. Immunol., October 1, 2003; 15(10): 1125 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Biermer, R. Puro, and R. J. Schneider Tumor Necrosis Factor Alpha Inhibition of Hepatitis B Virus Replication Involves Disruption of Capsid Integrity through Activation of NF-{kappa}B J. Virol., April 1, 2003; 77(7): 4033 - 4042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Samady, E. Costigliola, L. MacCormac, Y. McGrath, S. Cleverley, C. E. Lilley, J. Smith, D. S. Latchman, B. Chain, and R. S. Coffin Deletion of the Virion Host Shutoff Protein (vhs) from Herpes Simplex Virus (HSV) Relieves the Viral Block to Dendritic Cell Activation: Potential of vhs- HSV Vectors for Dendritic Cell-Mediated Immunotherapy J. Virol., March 15, 2003; 77(6): 3768 - 3776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Chen, Y.-P. Lee, Y.-F. Chung, Y.-C. Shih, J.-P. Tsai, M.-H. Tao, and C.-C. Ting Inducing long-term survival with lasting anti-tumor immunity in treating B cell lymphoma by a combined dendritic cell-based and hydrodynamic plasmid-encoding IL-12 gene therapy Int. Immunol., March 1, 2003; 15(3): 427 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kakimi, M. Isogawa, J. Chung, A. Sette, and F. V. Chisari Immunogenicity and Tolerogenicity of Hepatitis B Virus Structural and Nonstructural Proteins: Implications for Immunotherapy of Persistent Viral Infections J. Virol., July 29, 2002; 76(17): 8609 - 8620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. von Bergwelt-Baildon, R. H. Vonderheide, B. Maecker, N. Hirano, K. S. Anderson, M. O. Butler, Z. Xia, W. Y. Zeng, K. W. Wucherpfennig, L. M. Nadler, et al. Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application Blood, May 1, 2002; 99(9): 3319 - 3325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kakimi, T. E. Lane, S. Wieland, V. C. Asensio, I. L. Campbell, F. V. Chisari, and L. G. Guidotti Blocking Chemokine Responsive to {gamma}-2/Interferon (IFN)-{gamma} Inducible Protein and Monokine Induced by IFN-{gamma} Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus-specific Cytotoxic T Lymphocytes J. Exp. Med., December 17, 2001; 194(12): 1755 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Satoi, K. Murata, M. Lechmann, E. Manickan, Z. Zhang, H. Wedemeyer, B. Rehermann, and T. J. Liang Genetic Immunization of Wild-Type and Hepatitis C Virus Transgenic Mice Reveals a Hierarchy of Cellular Immune Response and Tolerance Induction against Hepatitis C Virus Structural Proteins J. Virol., December 15, 2001; 75(24): 12121 - 12127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Sette, C. Oseroff, J. Sidney, J. Alexander, R. W. Chesnut, K. Kakimi, L. G. Guidotti, and F. V. Chisari Overcoming T Cell Tolerance to the Hepatitis B Virus Surface Antigen in Hepatitis B Virus-Transgenic Mice J. Immunol., January 15, 2001; 166(2): 1389 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Voehringer, C. Blaser, A. B. Grawitz, F. V. Chisari, K. Buerki, and H. Pircher Break of T Cell Ignorance to a Viral Antigen in the Liver Induces Hepatitis J. Immunol., September 1, 2000; 165(5): 2415 - 2422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. de Vos, A. Fukushima, M. C. Lobanoff, B. P. Vistica, J. C. Lai, J.-C. Grivel, E. F. Wawrousek, S. M. Whitcup, and I. Gery Breakdown of Tolerance to a Neo-Self Antigen in Double Transgenic Mice in Which B Cells Present the Antigen J. Immunol., May 1, 2000; 164(9): 4594 - 4600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schirmbeck, J. Wild, D. Stober, H. E. Blum, F. V. Chisari, M. Geissler, and J. Reimann Ongoing Murine T1 or T2 Immune Responses to the Hepatitis B Surface Antigen Are Excluded from the Liver that Expresses Transgene-Encoded Hepatitis B Surface Antigen J. Immunol., April 15, 2000; 164(8): 4235 - 4243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Guidotti, H. McClary, J. M. Loudis, and F. V. Chisari Nitric Oxide Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice J. Exp. Med., April 3, 2000; 191(7): 1247 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Linette, S. Shankara, S. Longerich, S. Yang, R. Doll, C. Nicolette, F. I. Preffer, B. L. Roberts, and F. G. Haluska In Vitro Priming with Adenovirus/gp100 Antigen-Transduced Dendritic Cells Reveals the Epitope Specificity of HLA-A*0201-Restricted CD8+ T Cells in Patients with Melanoma J. Immunol., March 15, 2000; 164(6): 3402 - 3412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. McClary, R. Koch, F. V. Chisari, and L. G. Guidotti Relative Sensitivity of Hepatitis B Virus and Other Hepatotropic Viruses to the Antiviral Effects of Cytokines J. Virol., March 1, 2000; 74(5): 2255 - 2264. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Wang, M. N. Griffiths, D. R. Burton, and P. Ghazal Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization PNAS, January 18, 2000; 97(2): 847 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Ahuja, R. L. Reddick, N. Sato, E. Montalbo, V. Kostecki, W. Zhao, M. J. Dolan, P. C. Melby, and S. K. Ahuja Dendritic Cell (DC)-Based Anti-Infective Strategies: DCs Engineered to Secrete IL-12 Are a Potent Vaccine in a Murine Model of an Intracellular Infection J. Immunol., October 1, 1999; 163(7): 3890 - 3897. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
